# Aelin Therapeutics: Research, Leuven, Belgium

> Aelin Therapeutics: Aelin Therapeutics is a biotherapeutics company based in Belgium, founded in 2017 as a spin-off from VIB. Based in Leuven, Belgium.

Source: https://millionrounds.com/startup/aelin-therapeutics-2 (Millionrounds; every figure on the page links to its filing or article)

Belgium · [Research startup](https://millionrounds.com/companies)

# Aelin Therapeutics

Aelin Therapeutics is a biotherapeutics company based in Belgium, founded in 2017 as a spin-off from VIB.

Follow Aelin Therapeutics and see its new rounds in your feed. [Sign up free](https://millionrounds.com/login?join=1&why=follow&next=%2Fstartup%2Faelin-therapeutics-2)

Funding reported Last round: Series A

Research Leuven, Belgium

Company summary

- **Founded:** 2017 9 years old
- **Team:** 4 1 to 10 people
- **Funding reported:** 27M as listed, currency not stated
- **Last round:** Series A Dec 2017

How sure we are

- ✓ **Listed** We know it exists and what it does
- 2 **Funding reported** A company dataset reports a raise
- 3 **Observed** A filing or a dated announcement confirms a round

No round for Aelin Therapeutics has been confirmed by a filing or an announcement yet, so nothing here counts toward an investor's record. [How we decide](https://millionrounds.com/methodology)

## About Aelin Therapeutics

Aelin Therapeutics is a biotherapeutics company based in Belgium, founded in 2017 as a spin-off from VIB.

The company is focused on developing a unique class of peptide-based therapeutics known as Pept-insTM. These therapeutics induce targeted protein aggregation to effectively knock down disease-causing proteins, particularly in the areas of antibiotics and challenging human targets that are difficult to treat. Headquartered in Ghent and Leuven, Aelin Therapeutics has raised $31.86 million in a Series A funding round, attracting investments from notable firms such as PMV, LSP (now EQT Life Sciences), Boehringer Ingelheim Venture Fund, and Fund+. The company's innovative platform aims to address antibiotic resistance by creating new mechanisms that minimize the risk of resistance, paving the way for first-in-class drugs for diseases that are not effectively treated by traditional small molecules or antibodies.

## What company datasets say Aelin Therapeutics raised

Funding, as reported

Reported in all **27M** in the source's currency

Rounds **1**

Last round **Series A**

Last round size **31.8M**

Last round date **Dec 2017**

Investors listed **5**

## The company, in detail

What they build

Known for

biotechnology research high value selftargets protein aggregation antibiotics microbiology

Built with from their website

CloudFlare CDN Remote

- **Sector:** Research
- **Region:** Vlaanderen
- **Full record:** [Every detail in the company directory](https://millionrounds.com/directory/aelin-therapeutics)

## Research in Belgium

Startups like it

- [**Fyteko** Anderlecht · founded 2014 *Raised*](https://millionrounds.com/company/fyteko)
- [**Cellaïon** Mont-Saint-Guibert · founded 2021](https://millionrounds.com/startup/cella-on)
- [**Precirix** Jette · founded 2014](https://millionrounds.com/startup/precirix)
- [**Full-Life Technologies** Gembloux · founded 2021](https://millionrounds.com/startup/full-life-technologies)
- [**Augustine Therapeutics** Leuven · founded 2019](https://millionrounds.com/startup/augustine-therapeutics)
- [**NOVADIP Biosciences S.A.** Mont-Saint-Guibert · founded 2013](https://millionrounds.com/startup/novadip-biosciences-s-a)
- [**EyeD Pharma** Seraing · founded 2012](https://millionrounds.com/startup/eyed-pharma)
- [**atbtherapeutics** Marche-en-Famenne · founded 2018](https://millionrounds.com/startup/atbtherapeutics)

## Is this your company?

Add your raise, your deck and your story, and put Aelin Therapeutics in front of investors. Or tell us what we have wrong.

[List your startup](https://millionrounds.com/list-your-startup)[Send a correction](https://millionrounds.com/corrections)